China-based medical testing services company Wuhan Kindstar Diagnostics has secured $20m of series C investment in a round featuring medical research nonprofit organisation the Mayo Clinic, venture capital firm Kleiner Perkins Caufield & Byers’ China unit, VC firm WI Harper Group and private equity firm Baird Capital Partners, according to private equity network AltAssets.
Mayo, WI Harper and Baird all contributed to Wuhan’s $11m series B round in June last year alongside investment firm the Morningside Group’s VC division. Morningside previously funded Wuhan Kindstar’s series A round in 2008.